A Study of LY4152199 in Participants With Previously Treated B-cell Cancers and Leukemia

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

295

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

March 31, 2029

Conditions
Leukemia, Lymphocytic, Chronic, B-CellLymphoma, B-cell Marginal ZoneLymphoma, Non-HodgkinB-cell LymphomaWaldenstrom MacroglobulinemiaLymphoma, Mantle-CellLymphoma, Large B-Cell, DiffuseBurkitt LymphomaLymphoma, FollicularLeukemia, B-Cell
Interventions
DRUG

LY4152199 - IV

Administered by IV infusion

DRUG

LY4152199 - SC

Administered by SC injection

Trial Locations (39)

2100

Center for Cancer and Organ Diseases - Rigshospitalet, Copenhagen

3002

Peter MacCallum Cancer Centre, East Melbourne

3004

The Alfred Hospital, Melbourne, VIC

6009

Linear Clinical Research, Nedlands

10016

New York University (NYU) Clinical Cancer Center, New York

10065

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

28040

South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jimenez Diaz, Madrid

37203

SCRI Oncology Partners, Nashville

40138

IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant Orsola, Bologna

44195

Cleveland Clinic, Cleveland

48149

Universitaetsklinikum Muenster, Münster

52242

University of Iowa, Iowa City

53226

Froedtert Hospital and the Medical College of Wisconsin, Milwaukee

55905

Mayo Clinic - Rochester, Rochester

59037

CHU de Lille - Hopital Claude Huriez, Lille

60637

The University of Chicago Medical Center (UCMC), Chicago

66160

University of Kansas Cancer Center, Kansas City

75244

University of Texas Southwestern, Dallas

77030

MD Anderson Cancer Center, Houston

80131

Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli

80218

Colorado Blood Cancer Institute, Denver

80336

LMU Klinikum Muenchen-Campus Grosshadern, München

91010

City of Hope, Duarte

98104

Swedish Cancer Institute (SCI), Seattle

80045-2559

University of Colorado Denver - School of Medicine - Anschutz Medical Campus, Aurora

06520-8028

Yale University School of Medicine - Yale Cancer Center, New Haven

02215

Dana-Farber Cancer Institute, Boston

08903

Rutgers Cancer Institute of New Jersey, New Brunswick

M5G 1Z5

University Health Network (UHN) - Princess Margaret Cancer Centre, Toronto

277-8577

National Cancer Center Hospital East, Chiba

135-8550

Cancer Institute Hospital of JFCR, Tokyo

30-727

Pratia MCM Krakow, Krakow

60-185

AIDPORT Sp. z o.o., Skorzewo

03080

Seoul National University Hospital, Seoul

05505

Asan Medical Center, Seoul

08035

Hospital Universitario Vall d'Hebron, Barcelona

08908

Institut Catala d'Oncologia - L'Hospitalet, Barcelona

LS9 7TF

Leeds Teaching Hospitals NHS Trust, Leeds

OX3 9DU

Oxford University Hospitals NHS Foundation Trust, Oxford

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY